We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Palatin Technologies Inc New | AMEX:PTN | AMEX | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.01 | 0.50% | 2.00 | 2.07 | 1.89 | 1.99 | 259,938 | 23:00:04 |
From May 2023 to May 2024
CRANBURY, N.J., Sept. 22, 2023 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its fourth quarter and fiscal year end 2023 operating results on Thursday, September 28, 2023, before the open of the U.S. financial markets.
Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on September 28, 2023, at 11:00 a.m. ET. The conference call will include a review of the company's operating results and an update on programs under development.
Schedule for the Operating Results Press Release, Conference Call / Audio Webcast
| |
Q4 & Fiscal Year End 2023 Results Press Release
| 09/28/2023 at 7:30 a.m. ET
|
Q4 & Fiscal Year End 2023 Conference Call-Live | 09/28/2023 at 11:00 a.m. ET |
US Toll Free Dial-In Number: | 1-888-506-0062 |
International Dial-In Number: | 1-973-528-0011 |
Participant Access Code:
| 313946
|
Q4 & Fiscal Year End 2023 Conference Call-Replay | 09/28/2023-10/12/2023 |
US Toll Free Dial-In Number: | 1-877-481-4010 |
International Dial-In Number: | 1-919-882-2331 |
Participant Access Code: | 49135 |
The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com or by accessing this link.
About Palatin
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.palatin.com and follow Palatin on Twitter at @PalatinTech.
View original content to download multimedia:https://www.prnewswire.com/news-releases/palatin-to-report-fourth-quarter-and-fiscal-year-end-2023-results-teleconference-and-webcast-to-be-held-on-september-28-2023-301936500.html
SOURCE Palatin Technologies, Inc.
Copyright 2023 PR Newswire
1 Year Palatin Technologies Chart |
1 Month Palatin Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
